Research
Metabolic adaptation
THDBH120 is a novel long-acting dual GIPR/GLP-1R agonist that has superior weight loss and metabolic improvement effects in rodents and mammals.
THDBH120 may be a promising treatment option for obesity and metabolic disorders.
StrongSupportsmedium confidence
THDBH120 is a novel long-acting dual GIPR/GLP-1R agonist that has superior weight loss and metabolic improvement effects in rodents and mammals.
Why this rating
Based on study design from abstract.
Source
A novel GIPR/GLP-1R dual agonist improves systemic metabolism through differentially regulating inflammation and lipid metabolism in obesity
Feng Zhang et al. · Journal of Advanced Research · 2026
other
Read the paper This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →